Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 31 - 40 of about 8011

 
 


External Resources:



31.  Strategies to Identify Mesenchymal Stromal Cells in Minimally Manipulated Human Bone Marrow Aspirate Concentrate Lack Consensus.LinkIT
Ruoss S, Walker JT, Nasamran CA, Fisch KM, Paez CJ, Parekh JN, Ball ST, Chen JL, Ahmed SS, Ward SR
The American journal of sports medicine, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

32.  Awareness of Delirium by ICU Nurses.LinkIT
Asmar IT, Yaseen KS, Jaghama MK, Khawaja YF, Alwredat AA, Sadaqa MH
Critical care nursing quarterly, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

33.  Contact allergy and allergic contact dermatitis from benzalkonium chloride in a tertiary dermatology center in Melbourne, Australia.LinkIT
Dear K, Palmer A, Nixon R
Contact dermatitis Contact Dermatitis Contact allergy and allergic contact dermatitis from benzalkonium chloride in a tertiary dermatology center in Melbourne, Australia. 10.1111/cod.13826 Benzalkonium chloride (BAK) is a quaternary ammonium compound that is used widely as an antiseptic and preservative. It is a strong irritant and considered a weak sensitizer. To analyze the temporal trend of BAK sensitization and the demographics of sensitized patients. We conducted a single-center retrospective study of 7390 patients who were patch tested with BAK between January 1, 2003 and December 31, 2019. Of the 7390 patients who were patch tested to BAK, 108 (1.5%) had a positive reaction, with 21 reactions deemed clinically relevant (0.3% of total patch tested) and a further 5 doubtful reactions deemed clinically relevant, resulting in a total of 26 relevant reactions (0.4% of total patch tested). Common sources of exposure were ophthalmic drops (30.8%), topical antiseptic preparations (26.9%), cosmetics (15.4%), disinfectant solutions (11.5%), hand sanitizers (11.5%), and hand washes (7.7%). One fifth of patients with relevant reactions were health care workers. There has been a dramatic increase in the number of positive reactions since 2017, for reasons not totally clear. Contact allergy (CA) and allergic contact dermatitis (ACD) in response to BAK are now increasing at our center. Awareness of this trend is important, given that the coronavirus disease 2019 (COVID-19) pandemic is likely to further expose people to BAK. © 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd. Dear Kate K https://orcid.org/0000-0002-0302-8848 Occupational Dermatology Research and Education Centre, Skin Health Institute, Carlton, Victoria, Australia. Palmer Amanda A Occupational Dermatology Research and Education Centre, Skin Health Institute, Carlton, Victoria, Australia. Nixon Rosemary R Occupational Dermatology Research and Education Centre, Skin Health Institute, Carlton, Victoria, Australia. eng Journal Article 2021 03 03 England Contact Dermatitis 7604950 0105-1873 IM allergic contact dermatitis benzalkonium chloride 2021 01 30 2020 11 28 2021 02 03 2021 3 4 6 0 2021 3 4 6 0 2021 3 3 12 16 aheadofprint 33656745 10.1111/cod.13826 REFERENCES, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>34.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Allergic contact dermatitis from potassium sorbate and sorbic acid in topical pharmaceuticals and medical devices.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Dendooven E, Kerre S, Foubert K, Pieters L, Lambert J, Goossens A, Aerts O<br><font color=gray><i>Contact dermatitis Contact Dermatitis Allergic contact dermatitis from potassium sorbate and sorbic acid in topical pharmaceuticals and medical devices. 10.1111/cod.13829 The preservatives sorbic acid (SA) and potassium sorbate (PS) are considered rare skin sensitizers. PS-containing products always contain SA to a certain extent, and positivity to PS may reflect sensitization to SA. Their optimal patch-test conditions are unknown. To report on the outcome of testing with SA and PS in various concentrations and/or vehicles. Seventeen patients with allergic contact dermatitis from PS/SA-containing topical pharmaceuticals and medical devices were patch tested to SA 2% and 5% pet.; SA 1%, 2%, 3%, 5%. eth.; and/or SA 2% aq., whereas PS was patch tested 5% pet. and/or 5% aq. Only one patient, not tested to the ethanol preparations, presented with a (doubtful) positive reaction to SA 2% pet., while this remained negative in 13 patients who reacted to SA 2% eth. The preparations containing SA 5% pet.; 1%, 3%, and 5% eth.; and SA 2% aq. had little or no additional value. PS 5% pet. performed better than 5% aq., and always mirrored SA sensitization. Sensitization to SA and PS is probably underestimated. SA 2% eth. and PS 5% pet. are preferred for patch testing, and patients sensitized to SA should avoid PS-containing products. Potassium sorbate (PS) and sorbic acid (SA) are widely used preservatives. PS-containing products always contain some SA. Both are considered rare skin sensitizers, but contact allergy in response to them might be underestimated. SA 2% eth. and PS 5% pet., rather than SA 2% pet. and PS 5% aq., respectively, may be required to diagnose contact allergy from PS/SA-containing topical pharmaceuticals and medical devices. A positive patch test to PS reflects sensitization to SA, and patients sensitized to SA should also avoid PS-containing products. © 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd. Dendooven Ella E Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium. Research group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. Research group Natural Products & Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium. Kerre Stefan S Department of Dermatology, Imelda Hospital, Bonheiden, Belgium. Foubert Kenn K Research group Natural Products & Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium. Pieters Luc L Research group Natural Products & Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium. Lambert Julien J Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium. Research group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. Goossens An A Department of Dermatology, University Hospitals KU Leuven, Leuven, Belgium. Aerts Olivier O https://orcid.org/0000-0002-0076-2887 Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium. Research group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. eng Journal Article 2021 03 03 England Contact Dermatitis 7604950 0105-1873 IM allergic contact dermatitis compounded pharmaceutical creams iatrogenic medical devices potassium sorbate preservatives sorbic acid topical pharmaceutical products vehicles wound care products 2021 02 23 2020 11 06 2021 02 28 2021 3 4 6 0 2021 3 4 6 0 2021 3 3 12 16 aheadofprint 33656744 10.1111/cod.13829 REFERENCES, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>35.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Anaplastic diffuse large B-cell lymphoma cytologically diagnosed in pleural effusion: Report of two cases.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>AbdullGaffar B, Seliem R<br><font color=gray><i>Diagnostic cytopathology Diagn Cytopathol Anaplastic diffuse large B-cell lymphoma cytologically diagnosed in pleural effusion: Report of two cases. 10.1002/dc.24730 Diffuse large B-cell lymphoma (DLBCL) has some rare special subtypes. Anaplastic variant has the immunophenotypic and genotypic features of DLBCL, and is characterized by the presence of large bizarre hallmark-like and Reed-Sternberg-Hodgkin-like cells. Lymphoblastic lymphoma and DLBCL, non-otherwise specified are the most common lymphoma effusions in adults. Lymphomas in effusion fluids usually show a homogenous uniform population of either small, medium or large cells depending on lymphoma types. Anaplastic pleomorphic lymphoid cells in pleural effusions are not common cytologic findings. Effusions due to lymphomas with large bizarre anaplastic cells, such as anaplastic large cell lymphoma and Hodgkin lymphomas, are rare. Presence of anaplastic cells in effusion fluid is diagnostically challenging. They may be confused with nonlymphoid malignancies. Certain cytomorphologic features are helpful clues. Ancillary immunocytochemistry is a useful confirmatory tool in doubtful cases. We report two cases of anaplastic variant-DLBCL (ADLBCL) cytologically diagnosed in elderly female patients with bilateral pleural effusions. Cytologic examination of effusion fluids showed predominantly medium-large mononuclear uniform cells intermixed with frequent large pleomorphic mononuclear and binucleated cells, and bizarre multinucleated giant cells. Background showed karyorrhexis and absent mixed inflammatory infiltrates. A panel of immunocytochemistry markers in cell block sections confirmed B-cell phenotype of the neoplastic and anaplastic cells. Lymph node biopsy supplemented with immunohistochemistry confirmed the cytologic diagnosis. Even though the presence of anaplastic cells may be confused with other malignancies, cytopathologists should consider ADLBCL in the differential diagnosis of lymphomas with large pleomorphic cells, look for certain cytomorphologic clues and implement an appropriate immunocytochemistry panel. © 2021 Wiley Periodicals LLC. AbdullGaffar Badr B https://orcid.org/0000-0001-6350-1214 Pathology Section, Rashid Hospital, Dubai, United Arab Emirates. Seliem Rania R Pathology Section, Rashid Hospital, Dubai, United Arab Emirates. eng Journal Article 2021 02 25 United States Diagn Cytopathol 8506895 1097-0339 IM anaplastic diffuse large B-cell effusion lymphoma 2021 01 15 2021 02 09 2021 02 11 2021 2 25 8 40 2021 2 26 6 0 2021 2 26 6 0 aheadofprint 33629814 10.1002/dc.24730 REFERENCES, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>36.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title><sup>68</sup>Ga-PSMA-11 PET/CT in patients with occult biochemical recurrence of prostate carcinoma and negative <sup>18</sup>F-Choline PET/CT. Preliminary assessment of its clinical use.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Plaza López PJ, Puertas E, Aguiló JJ, Suarez-Piñera M, Domenech B, Mestre-Fusco A, Casals J, Chicharo de Fleitas JR<br><font color=gray><i>Actas urologicas espanolas, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>37.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Research in the retirement village community-The problems of recruiting a representative cohort of residents in Auckland, New Zealand.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Joseph Connolly M, Hikaka J, Bloomfield K, Broad J, Wu Z, Boyd M, Peri K, Calvert C, Tatton A, Higgins AM, Bramley D<br><font color=gray><i>Australasian journal on ageing Australas J Ageing Research in the retirement village community-The problems of recruiting a representative cohort of residents in Auckland, New Zealand. 10.1111/ajag.12898 Retirement villages are semi-closed communities, access usually being gained via village managers. This paper explores issues recruiting a representative resident cohort, as background to a study of residents, to acquire sociodemographic, health and disability data and trial an intervention designed to improve outcomes. We planned approaching all Auckland/Waitemat? District villages and, via managers, contacting residents ('letter-drop'; 'door-knocks'). In 'small' villages (n ? 60 units), we planned contacting all residents, randomly selecting in 'larger' villages. We excluded those with doubtful or absent legal capacity. We approached managers of 53 of 65 villages. Thirty-four permitted recruitment. Some prohibited 'letter-drops' and/or 'door-knocks'. Hence, we recruited volunteers (23 villages) via meetings, posters, newsletters and word-of-mouth, that is representative sampling obtained from 11/34 villages. We recruited 578 residents (median age = 82 years; 420 = female; 217:361 sampled:volunteers), finding differences in baseline parameters of sampled vs. volunteers. Due to organisational/managers' policy, and national legislation restrictions, our sample does not represent our intended population well. Researchers should investigate alternative data sources, for example electoral rolls and censuses. © 2021 AJA Inc. Joseph Connolly Martin M https://orcid.org/0000-0002-1933-3345 Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. Waitemat? District Health Board, Auckland, New Zealand. Hikaka Joanna J https://orcid.org/0000-0001-6792-6607 Waitemat? District Health Board, Auckland, New Zealand. Bloomfield Katherine K https://orcid.org/0000-0001-6679-1763 Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. Waitemat? District Health Board, Auckland, New Zealand. Broad Joanna J Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. Wu Zhenqiang Z Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. Boyd Michal M Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. School of Nursing, University of Auckland, Auckland, New Zealand. Peri Kathy K https://orcid.org/0000-0002-3630-137X School of Nursing, University of Auckland, Auckland, New Zealand. Calvert Cheryl C Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. Auckland District Health Board, Auckland, New Zealand. Tatton Annie A Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. Waitemat? District Health Board, Auckland, New Zealand. Higgins Ann-Marie AM Department of Geriatric Medicine, University of Auckland and Waitemat? District Health Board, Auckland, New Zealand. Bramley Dale D Waitemat? District Health Board, Auckland, New Zealand. eng UOOX1508 New Zealand National Science Challenge Ageing Well 12815/1 New Zealand National Science Challenge Ageing Well SUB1301 New Zealand National Science Challenge Ageing Well Waitemata District Health Board Journal Article 2021 02 16 Australia Australas J Ageing 9808874 1440-6381 IM aging in place housing for the elderly patient selection selection bias 2020 05 14 2020 10 22 2020 10 26 2021 2 17 6 3 2021 2 18 6 0 2021 2 18 6 0 aheadofprint 33594804 10.1111/ajag.12898 REFERENCES, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>38.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Goldmann-Favre/Enhanced S Cone Syndrome, 30 years mysdiagnosed as gyrate atrophy.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>García Caride S, López Guajardo L, Donate López J<br><font color=gray><i>American journal of ophthalmology case reports, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>39.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Erythropoietin-Induced Hypertension: A Review of Pathogenesis, Treatment, and Role of Blood Viscosity.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Brar SK, Perveen S, Chaudhry MR, AlBabtain S, Amreen S, Khan S<br><font color=gray><i>Cureus, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>40.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>[Multimodal imaging in atypical choroidal nevus].</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Mahjoub A, Salah SH, Mhamdi T, Abdesslem NB, Ghorbel M, Mahjoub H<br><font color=gray><i>The Pan African medical journal, 2020</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br><br><br><table cellspacing=0 cellpadding=0 align=center><tr valign=bottom><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=3><img src=p.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=1><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=2><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=3><img src=o_yellow.png border=0></a></td><td align=center><img src=o_red.png border=0></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=5><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=6><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=7><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=8><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=9><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=10><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=11><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=12><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=13><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=5><img src=rtal.png border=0></a></td></tr><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=3>«</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=1>1</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=2>2</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=3>3</a></td><td align=center>4</td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=5>5</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=6>6</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=7>7</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=8>8</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=9>9</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=10>10</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=11>11</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=12>12</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=13>13</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=doubtful+knight%27s-spur&category=l&client=pubmed&startPage=5>»</a></td></tr></table></table></tr></table></td><script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-634822-1"; urchinTracker(); </script> </BODY> </HTML>